These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16699963)

  • 1. Private-sector research ethics: marketing or good conflicts management? The 2005 John J. Conley Lecture on Medical Ethics.
    Dresser R
    Theor Med Bioeth; 2006; 27(2):115-39. PubMed ID: 16699963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Industry support and professional medical associations.
    Jackson RH
    JAMA; 2009 Aug; 302(7):738; author reply 739. PubMed ID: 19690304
    [No Abstract]   [Full Text] [Related]  

  • 3. [Transparency in relations between multinational R&D pharmaceutical companies' corporate social responsibility activities and patient organizations in the Europe, Japan, and the United States].
    Kato M; Ishikawa H; Okuhara T; Kiuchi T
    Nihon Koshu Eisei Zasshi; 2019; 66(12):746-755. PubMed ID: 31875625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human rights responsibilities of pharmaceutical companies in relation to access to medicines.
    Lee JY; Hunt P
    J Law Med Ethics; 2012; 40(2):220-33. PubMed ID: 22789042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Putting the "ethics" into "research ethics".
    Spike J
    Am J Bioeth; 2005; 5(1):51-3; author reply W15-8. PubMed ID: 16036663
    [No Abstract]   [Full Text] [Related]  

  • 6. Industry support and professional medical associations.
    Smith CD; Buyske J; Talamini MA
    JAMA; 2009 Aug; 302(7):738-9; author reply 739. PubMed ID: 19690303
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to open peer commentaries on "How to do research fairly in an unjust world".
    Ballantyne AJ
    Am J Bioeth; 2010 Jun; 10(6):W4-6. PubMed ID: 20526959
    [No Abstract]   [Full Text] [Related]  

  • 8. Industry and medicine: conflicting interests and the power of money.
    Popovsky MA; Garcia N
    Transfusion; 2007 Jun; 47(6):1098-9. PubMed ID: 17524103
    [No Abstract]   [Full Text] [Related]  

  • 9. The corporate social responsibility of the pharmaceutical industry: idealism without illusion and realism without resignation.
    Leisinger KM
    Bus Ethics Q; 2005 Oct; 15(4):577-94. PubMed ID: 16358443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical and political problems with a global research tax.
    Resnik DB
    Am J Bioeth; 2010 Jun; 10(6):44-5. PubMed ID: 20526971
    [No Abstract]   [Full Text] [Related]  

  • 11. Corporate moral culpability in health care: when the implications don't fit the crime.
    Harter TD
    Am J Bioeth; 2011 Sep; 11(9):12-3. PubMed ID: 21877964
    [No Abstract]   [Full Text] [Related]  

  • 12. Review article: gastroenterology and the pharmaceutical industry.
    Rakatansky H
    Aliment Pharmacol Ther; 2002 Nov; 16(11):1859-66. PubMed ID: 12390094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to do research fairly in an unjust world.
    Ballantyne AJ
    Am J Bioeth; 2010 Jun; 10(6):26-35. PubMed ID: 20526966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combating corruption in the pharmaceutical arena.
    Lexchin J; Kohler JC; Gagnon MA; Crombie J; Thacker P; Shnier A
    Indian J Med Ethics; 2018; 3(3):234-239. PubMed ID: 29550750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ethics of the medical-pharmaceutical relationship.
    Vashi NA; Latkowski JA
    Clin Dermatol; 2012; 30(2):188-91. PubMed ID: 22330662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical ethics, research and the pharmaceutical industry.
    Abud-Mendoza C
    Reumatol Clin; 2012; 8(5):233-5. PubMed ID: 22608694
    [No Abstract]   [Full Text] [Related]  

  • 17. Managing physician financial conflicts of interest in clinical trials conducted in the private practice setting.
    Williams KM
    Food Drug Law J; 2004; 59(1):45-77. PubMed ID: 15190925
    [No Abstract]   [Full Text] [Related]  

  • 18. Too friendly? Teaching hospitals revisit ties to pharmaceutical firms.
    Romano M
    Mod Healthc; 2003 Jul; 33(28):17. PubMed ID: 12884711
    [No Abstract]   [Full Text] [Related]  

  • 19. Developing drugs for the developing world: an economic, legal, moral, and political dilemma.
    Resnik DB
    Dev World Bioeth; 2001 May; 1(1):11-32. PubMed ID: 12870505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.
    Tereskerz PM
    Account Res; 2003; 10(3):137-58. PubMed ID: 14979317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.